|
Volumn 3, Issue 3, 2007, Pages 305-307
|
Update on Alzheimer's and Parkinson's diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA SYNUCLEIN;
AMYLOID BETA PROTEIN;
APOLIPOPROTEIN E;
BIOLOGICAL MARKER;
CHOLINESTERASE INHIBITOR;
DIMEBON;
LEVODOPA;
PLACEBO;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
ALZHEIMER DISEASE;
ARTICLE;
BIOCHEMISTRY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEGENERATIVE DISEASE;
DRUG ACTIVITY;
DRUG EFFICACY;
GENETIC ANALYSIS;
GENETIC ASSOCIATION;
GENETIC SUSCEPTIBILITY;
HUMAN;
NONHUMAN;
OLIGOMERIZATION;
PARKINSON DISEASE;
PATHOGENESIS;
SYMPTOM;
|
EID: 34250830185
PISSN: 1745509X
EISSN: 17455103
Source Type: Journal
DOI: 10.2217/1745509X.3.3.305 Document Type: Article |
Times cited : (1)
|
References (2)
|